Shai Mulinari

17PUBLICATIONS
19CO-AUTHORS
Genomics and transcriptomicsPricing (incl. consumer value estimation)Commercial lawNot-for-profit finance and riskPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Dec 08, 2025
Aligning digital biomarker definitions in psychiatry with the National Institute of Mental Health Research Domain Criteria framework.

Shai Mulinari

|Aug 08, 2025
Pharmaceutical company promotional payments to English general practices: a longitudinal study.

Shai Mulinari, Minahil Malik, James Larkin

|Jan 08, 2025
Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation.

Piotr Ozieranski, Emily Rickard, Shai Mulinari

|Dec 27, 2024
Pharmaceutical Industry Payments to Patient Organizations in Poland: Analysis of the Patterns, Evolution, and Structure of Connections.

Marta Makowska, Shai Mulinari, Piotr Ozieranski

|Jul 11, 2024
Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals.

Hayase Hakariya, Frank Moriarty, Akihiko Ozaki

|Nov 01, 2023
Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database.

Piotr Ozieranski, Eszter Saghy, Shai Mulinari

Pageof 3

Frequent Collaborators

5 joint publications

Piotr Ozieranski

2 joint publications

Andreas Vilhelmsson

2 joint publications

Emily Rickard

2 joint publications

Anna Bredström